Tirzepatide | 60mg Lyophilized

Tirzepatide is a dual agonist peptide that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating these pathways, tirzepatide supports glucose regulation, appetite control and metabolic function.

Weight Management Benefits

• Appetite Suppression: Tirzepatide acts on pathways involved in appetite regulation, which may increase feelings of fullness and reduce hunger and food intake.

• Delayed Gastric Emptying: GLP-1 receptor activity can slow gastric emptying, contributing to prolonged feelings of fullness after meals.

• Metabolic Function: Tirzepatide's activity at GIP receptors contributes to its effects on glucose and energy metabolism.

• Enhanced Glucose Homeostasis: Tirzepatide promotes glucose-dependent insulin secretion and helps regulate glucagon levels, supporting healthy blood glucose regulation.

• Weight Reduction: Clinical trials have demonstrated significant reductions in body weight among eligible adults treated with tirzepatide, particularly when combined with appropriate diet and physical activity.

The effects of tirzepatide are associated with its dual mechanism of action at both GIP and GLP-1 receptors. Clinical studies have demonstrated its effectiveness in supporting blood glucose management and weight reduction in appropriate patient populations.

Content & Potency

Injectable Liquid Formulation:

• 60mg Tirzepatide

• Injectable liquid formulation

• Supplied in a vial

• Ready-to-use liquid formulation

• No reconstitution required

Important Information

This product is intended for use only as directed by an appropriately qualified healthcare professional. Tirzepatide is a prescription medicine and should only be used following appropriate medical assessment and guidance. Store and handle the product according to the manufacturer's instructions.